Debrisoquin (hydrobromide)
Debrisoquine (Ro 5-3307/1) hydrobromide is a TMPRSS2 inhibitors that inhibits SARS-CoV-2 entry into human lung cell line by a TMPRSS2-depedent manner, with an IC50 of 22μM. Debrisoquine hydrobromide can be used for antiviral research[1].
Product Specifications
CAS Number
1131-65-3
Product Name Alternative
Debrisoquine (hydrobromide) ; Isocaramidine (hydrobromide) ; Ro 5-3307/1 (hydrobromide)
UNSPSC
12352005
Target
SARS-CoV; Ser/Thr Protease
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Infection
Smiles
N=C(N1CC2=C(CC1)C=CC=C2)N.Br
Molecular Formula
C10H14BrN3
Molecular Weight
256.14
References & Citations
[1]Amanda L. Peiffer, et.al.TMPRSS2 Inhibitor Discovery Facilitated through an In Silico and Biochemical Screening Platform.ACS Medicinal Chemistry Letters 2023 14 (6), 860-866.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS8521631-02 0.1 mL (AF635)
Casein Kinase I delta Polyclonal Antibody
Sign In for Pricing
View Details MBS8521631-03 0.1 mL (AF610)
Casein Kinase I delta Polyclonal Antibody
Sign In for Pricing
View Details MBS8521631-04 0.1 mL (AF405S)
Casein Kinase I delta Polyclonal Antibody
Sign In for Pricing
View Details MBS8521631-05 0.1 mL (AF405L)
Casein Kinase I delta Polyclonal Antibody
Sign In for Pricing
View Details MBS8521631-06 0.1 mL (AF546)
Casein Kinase I delta Polyclonal Antibody
Sign In for Pricing
View Details